Skip to main content

Glenmark Pharmaceuticals Ltd (GLENMARK)

Glenmark Pharmaceuticals Ltd share price, charts, financials, and analysis on WealthOrbit.

Glenmark Pharmaceuticals Ltd

Healthcarelarge_cap

GLENMARK · BSE · Drug Manufacturers - Specialty & Generic

2,290
-2.02%-47.2

Live · Prev close ₹2,337.2

Market Cap

₹64.9 K

P/E

60.97x

P/B

6.77x

ROE

0.09%

ROCE

20.13%

D/E

0.13

Div Yield

22%

Book Val

₹339.57

Price Ranges

Day Low: ₹2,283.4Day High: ₹2,371.6
52W Low: ₹1,340.3552W High: ₹2,371.6

Price Chart

No chart data available

Returns

Analysis· Based on latest data

Pros

  • Good ROCE of 20.1%
  • Low debt-to-equity ratio of 0.13 — conservatively funded
  • Attractive dividend yield of 22.00%
  • Healthy operating margin of 18.3%

Cons

  • Stock trading at high P/E of 61.0x — premium valuation
  • High P/B ratio of 6.8x — above book value premium
  • Low return on equity of 0.1% over last year

* Auto-generated from financial ratios. Do your own analysis before investing.

Company Info

ISIN

INE935A01035

Series

A

Industry

Drug Manufacturers - Specialty & Generic

Listed

10 Feb 2000

HQ

Mumbai, India

Face Val

₹1

Glenmark Pharma Ltd is a leading company in the Pharmaceuticals space, listed on NSE and BSE.

Fundamentals

TTM P/E60.97x
P/B Ratio6.77x
EPS (TTM)₹37.69
ROE0.09%
ROCE20.13%
Debt / Equity0.13
Revenue (TTM)₹16.5 K
Net Profit (TTM)₹1.1 K
Promoter Holding48.96%

Peer Comparison